Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exosomes for cancer immunotherapy.
Andre F, Escudier B, Angevin E, Tursz T, Zitvogel L. Andre F, et al. Among authors: tursz t. Ann Oncol. 2004;15 Suppl 4:iv141-4. doi: 10.1093/annonc/mdh918. Ann Oncol. 2004. PMID: 15477298 Free article. Review. No abstract available.
Malignant effusions and immunogenic tumour-derived exosomes.
Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L. Andre F, et al. Among authors: tursz t. Lancet. 2002 Jul 27;360(9329):295-305. doi: 10.1016/S0140-6736(02)09552-1. Lancet. 2002. PMID: 12147373
Dendritic cell-based immunotherapy of cancer.
Zitvogel L, Angevin E, Tursz T. Zitvogel L, et al. Among authors: tursz t. Ann Oncol. 2000;11 Suppl 3:199-205. doi: 10.1093/annonc/11.suppl_3.199. Ann Oncol. 2000. PMID: 11079142 Free article. Review. No abstract available.
Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection.
Chaput N, Schartz NE, André F, Taïeb J, Novault S, Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M, Adema G, Adams M, Ferrantini M, Carpentier AF, Escudier B, Tursz T, Angevin E, Zitvogel L. Chaput N, et al. Among authors: tursz t. J Immunol. 2004 Feb 15;172(4):2137-46. doi: 10.4049/jimmunol.172.4.2137. J Immunol. 2004. PMID: 14764679
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial.
Escudier B, Dorval T, Chaput N, André F, Caby MP, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S, Boccaccio C, Bonnerot C, Dhellin O, Movassagh M, Piperno S, Robert C, Serra V, Valente N, Le Pecq JB, Spatz A, Lantz O, Tursz T, Angevin E, Zitvogel L. Escudier B, et al. Among authors: tursz t. J Transl Med. 2005 Mar 2;3(1):10. doi: 10.1186/1479-5876-3-10. J Transl Med. 2005. PMID: 15740633 Free PMC article.
Dendritic cell-derived exosomes for cancer immunotherapy: what's next?
Viaud S, Théry C, Ploix S, Tursz T, Lapierre V, Lantz O, Zitvogel L, Chaput N. Viaud S, et al. Among authors: tursz t. Cancer Res. 2010 Feb 15;70(4):1281-5. doi: 10.1158/0008-5472.CAN-09-3276. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145139 Review.
274 results